Platelets are versatile cells: New discoveries in hemostasis, thrombosis, immune responses, tumor metastasis and beyond

References

• Coller BS. Foreword: a brief history of ideas about platelets in health and disease. In: Michelson AD, ed. Platelets. 3rd ed. Amsterdam: Academic Press/Elsevier, 2013:xix–xliv
   Google Scholar
• Wang Y, Andrews M, Yang Y, et al. Platelets in thrombosis and hemostasis: old topic with new mechanisms. Cardiovasc Hematol Disord Drug Targets 2012;12:126–32
   PubMedGoogle Scholar
• Ruggeri ZM. Platelets in atherothrombosis. Nat Med 2002;8:1227–34
   PubMed Web of Science ®Google Scholar
• Li C, Li J, Li Y, et al. Crosstalk between platelets and the immune system: old systems with new discoveries. Adv Hematol 2012;2012:384685
   PubMedGoogle Scholar
• Semple JW, Italiano JE, Jr Freedman J. Platelets and the immune continuum. Nat Rev Immunol 2011;11:264–74
   PubMed Web of Science ®Google Scholar
• Siegel-Axel D, Daub K, Seizer P, et al. Platelet lipoprotein interplay: trigger of foam cell formation and driver of atherosclerosis. Cardiovasc Res 2008;78:8–17
   PubMed Web of Science ®Google Scholar
• Lindemann S, Kramer B, Seizer P, Gawaz M. Platelets, inflammation and atherosclerosis. J Thromb Haemost 2007;5:203–11
   PubMed Web of Science ®Google Scholar
• Murphy AJ, Bijl N, Yvan-Charvet L, et al. Cholesterol efflux in megakaryocyte progenitors suppresses platelet production and thrombocytosis. Nat Med 2013;19:586–94
   PubMed Web of Science ®Google Scholar
• Hess PR, Rawnsley DR, Jakus Z, et al. Platelets mediate lymphovenous hemostasis to maintain blood-lymphatic separation throughout life. J Clin Invest 2014;124:273–84
   PubMed Web of Science ®Google Scholar
• Navarro-Nunez L, Langan SA, Nash GB, Watson SP. The physiological and pathophysiological roles of platelet CLEC-2. Thromb Haemost 2013;109:991–8
   PubMed Web of Science ®Google Scholar
• Osada M, Inoue O, Ding G, et al. Platelet activation receptor CLEC-2 regulates blood/lymphatic vessel separation by inhibiting proliferation, migration, and tube formation of lymphatic endothelial cells. J Biol Chem 2012;287:22241–52
   PubMed Web of Science ®Google Scholar
• Herzog BH, Fu J, Wilson SJ, et al. Podoplanin maintains high endothelial venule integrity by interacting with platelet CLEC-2. Nature 2013;502:105–9
   PubMed Web of Science ®Google Scholar
• Italiano JE, Jr., Richardson JL, Patel-Hett S, et al. Angiogenesis is regulated by a novel mechanism: pro- and antiangiogenic proteins are organized into separate platelet alpha granules and differentially released. Blood 2008;111:1227–33
   PubMed Web of Science ®Google Scholar
• Chatterjee M, Huang Z, Zhang W, et al. Distinct platelet packaging, release, and surface expression of proangiogenic and antiangiogenic factors on different platelet stimuli. Blood 2011;117:3907–11
   PubMed Web of Science ®Google Scholar
• Yougbare I, Lang S, Yang H, et al. Maternal anti-platelet β3 integrins impair angiogenesis and cause intracranial hemorrhage. J Clin Invest 2015;125:1545–56
   PubMed Web of Science ®Google Scholar
• Labelle M, Hynes RO. The initial hours of metastasis: the importance of cooperative host-tumor cell interactions during hematogenous dissemination. Cancer Discov 2012;2:1091–9
   PubMed Web of Science ®Google Scholar
• Labelle M, Begum S, Hynes RO. Platelets guide the formation of early metastatic niches. Proc Natl Acad Sci USA 2014;111:E3053–61
   PubMed Web of Science ®Google Scholar
• Franco AT, Corken A, Ware J. Platelets at the interface of thrombosis, inflammation, and cancer. Blood 2015;126:582–8
   PubMed Web of Science ®Google Scholar
• Hartwig JH. Chapter 8: the platelet cytoskeleton. In: Michelson AD, ed. Platelets. 3rd ed. Amsterdam: Academic Press/Elsevier, 2013:145–68
   Google Scholar
• Jackson SP, Nesbitt WS, Westein E. Dynamics of platelet thrombus formation. J Thromb Haemost 2009;7:17–20
   PubMed Web of Science ®Google Scholar
• Nakamura F, Stossel TP, Hartwig JH. The filamins: organizers of cell structure and function. Cell Adh Migr 2011;5:160–9
   PubMed Web of Science ®Google Scholar
• Wang H, Bang KW, Blanchette VS, et al. Phosphatidylserine exposure, microparticle formation and mitochondrial depolarisation in Glanzmann thrombasthenia platelets. Thromb Haemost 2014;111:1184–6
   PubMed Web of Science ®Google Scholar
• Roberts HR, Hoffman M, Monroe DM. A cell-based model of thrombin generation. Semin Thromb Hemost 2006;32:32–8
   PubMed Web of Science ®Google Scholar
• Monroe DM, Hoffman M, Roberts HR. Platelets and thrombin generation. Arterioscler Thromb Vasc Biol 2002;22:1381–9
   PubMed Web of Science ®Google Scholar
• Choi W, Karim ZA, Whiteheart SW. Protein expression in platelets from six species that differ in their open canalicular system. Platelets 2010;21:167–75
   PubMed Web of Science ®Google Scholar
• Heijnen H, van der Sluijs P. Platelet secretory behaviour: as diverse as the granules or not? J Thromb Haemost 2015;13:2141–51
   PubMed Web of Science ®Google Scholar
• Jonnalagadda D, Izu LT, Whiteheart SW. Platelet secretion is kinetically heterogeneous in an agonist-responsive manner. Blood 2012;120:5209–16
   PubMed Web of Science ®Google Scholar
• Wang Y, Vachon E, Zhang J, et al. Tyrosine phosphatase MEG2 modulates murine development and platelet and lymphocyte activation through secretory vesicle function. J Exp Med 2005;202:1587–97
   PubMed Web of Science ®Google Scholar
• Mountford JK, Petitjean C, Putra HW, et al. The class II PI 3-kinase, PI3KC2α, links platelet internal membrane structure to shear-dependent adhesive function. Nat Commun 2015;6:6535
   PubMed Web of Science ®Google Scholar
• Reheman A, Gross P, Yang H, et al. Vitronectin stabilizes thrombi and vessel occlusion but plays a dual role in platelet aggregation. J Thromb Haemost 2005;3:875–83
   PubMed Web of Science ®Google Scholar
• Wang Y, Gallant RC, Ni H. Extracellular matrix proteins in the regulation of thrombus formation. Curr Opin Hematol 2016;23:280–7
   PubMed Web of Science ®Google Scholar
• Reheman A, Tasneem S, Ni H, Hayward CP. Mice with deleted multimerin 1 and alpha-synuclein genes have impaired platelet adhesion and impaired thrombus formation that is corrected by multimerin 1. Thromb Res 2010;125:e177–83
   PubMed Web of Science ®Google Scholar
• Von Hundelshausen P, Petersen F, Brandt E. Platelet-derived chemokines in vascular biology. Thromb Haemost 2007;97:704–13
   PubMed Web of Science ®Google Scholar
• Klinger MH, Jelkmann W. Role of blood platelets in infection and inflammation. J Interferon Cytokine Res 2002;22:913–22
   PubMed Web of Science ®Google Scholar
• Kraemer BF, Campbell RA, Schwertz H, et al. Novel anti-bacterial activities of β-defensin 1 in human platelets: suppression of pathogen growth and signaling of neutrophil extracellular trap formation. PLoS Pathog 2011;7:e1002355
   PubMed Web of Science ®Google Scholar
• Gleissner CA, von Hundelshausen P, Ley K. Platelet chemokines in vascular disease. Arterioscler Thromb Vasc Biol 2008;28:1920–7
   PubMed Web of Science ®Google Scholar
• Koenen RR, von Hundelshausen P, Nesmelova IV, et al. Disrupting functional interactions between platelet chemokines inhibits atherosclerosis in hyperlipidemic mice. Nat Med 2009;15:97–103
   PubMed Web of Science ®Google Scholar
• Morrissey JH, Choi SH, Smith SA. Polyphosphate: an ancient molecule that links platelets, coagulation, and inflammation. Blood 2012;119:5972–9
   PubMed Web of Science ®Google Scholar
• Müller F, Mutch NJ, Schenk WA, et al. Platelet polyphosphates are proinflammatory and procoagulant mediators in vivo. Cell 2009;139:1143–56
   PubMed Web of Science ®Google Scholar
• Conway EM. Reincarnation of ancient links between coagulation and complement. J Thromb Haemost 2015;13:S121–32
   PubMed Web of Science ®Google Scholar
• White GC, Rompietti R. Platelet secretion: indiscriminately spewed forth or highly orchestrated? J Thromb Haemost 2007;5:2006–8
   PubMed Web of Science ®Google Scholar
• Ren Q, Ye S, Whiteheart SW. The platelet release reaction: just when you thought platelet secretion was simple. Curr Opin Hematol 2008;15:537–41
   PubMed Web of Science ®Google Scholar
• Kamykowski J, Carlton P, Sehgal S, Storrie B. Quantitative immunofluorescence mapping reveals little functional coclustering of proteins within platelet α-granules. Blood 2011;118:1370–3
   PubMed Web of Science ®Google Scholar
• Cattaneo M. Inherited platelet-based bleeding disorders. J Thromb Haemost 2003;1:1628–36
   PubMed Web of Science ®Google Scholar
• Drouin A, Favier R, Masse JM, et al. Newly recognized cellular abnormalities in the gray platelet syndrome. Blood 2001;98:1382–91
   PubMed Web of Science ®Google Scholar
• Kahr WH, Hinckley J, Li L, et al. Mutations in NBEAL2, encoding a BEACH protein, cause gray platelet syndrome. Nat Genet 2011;43:738–40
   PubMed Web of Science ®Google Scholar
• Tracy PB, Giles AR, Mann KG, et al. Factor V (Quebec): a bleeding diathesis associated with a qualitative platelet Factor V deficiency. J Clin Invest 1984;74:1221–8
   PubMed Web of Science ®Google Scholar
• Blair P, Flaumenhaft R. Platelet alpha-granules: basic biology and clinical correlates. Blood Rev 2009;23:177–89
   PubMed Web of Science ®Google Scholar
• Ni H, Papalia JM, Degen JL, Wagner DD. Control of thrombus embolization and fibronectin internalization by integrin alpha IIb beta 3 engagement of the fibrinogen gamma chain. Blood 2003;102:3609–14
   PubMed Web of Science ®Google Scholar
• Zhai Z, Wu J, Xu X, et al. Fibrinogen controls human platelet fibronectin internalization and cell-surface retention. J Thromb Haemost 2007;5:1740–6
   PubMed Web of Science ®Google Scholar
• Machlus KR, Italiano JE, Jr. The incredible journey: from megakaryocyte development to platelet formation. J Cell Biol 2013;201:785–96
   PubMed Web of Science ®Google Scholar
• Weyrich AS, Schwertz H, Kraiss LW, Zimmerman GA. Protein synthesis by platelets: historical and new perspectives. J Thromb Haemost 2009;7:241–6
   PubMed Web of Science ®Google Scholar
• Yang H, Lang S, Zhai Z, et al. Fibrinogen is required for maintenance of platelet intracellular and cell-surface P-selectin expression. Blood 2009;114:425–36
   PubMed Web of Science ®Google Scholar
• Schwertz H, Zimmerman GA, Weyrich AS. Fibrinogen selects selectins. Blood 2009;114:234
   PubMed Web of Science ®Google Scholar
• Schwertz H, Koster S, Kahr WH, et al. Anucleate platelets generate progeny. Blood 2010;115:3801–9
   PubMed Web of Science ®Google Scholar
• Zimmerman GA, Weyrich AS. Signal-dependent protein synthesis by activated platelets: new pathways to altered phenotype and function. Arterioscler Thromb Vasc Biol 2008;28:s17–24
   PubMed Web of Science ®Google Scholar
• Denis MM, Tolley ND, Bunting M, et al. Escaping the nuclear confines: signal-dependent pre-mRNA splicing in anucleate platelets. Cell 2005;122:379–91
   PubMed Web of Science ®Google Scholar
• Weyrich AS, Denis MM, Schwertz H, et al. mTOR-dependent synthesis of Bcl-3 controls the retraction of fibrin clots by activated human platelets. Blood 2007;109:1975–83
   PubMed Web of Science ®Google Scholar
• Panes O, Matus V, Saez CG, et al. Human platelets synthesize and express functional tissue factor. Blood 2007;109:5242–50
   PubMed Web of Science ®Google Scholar
• Brogren H, Karlsson L, Andersson M, et al. Platelets synthesize large amounts of active plasminogen activator inhibitor 1. Blood 2004;104:3943–8
   PubMed Web of Science ®Google Scholar
• Evangelista V, Manarini S, Di Santo A, et al. De novo synthesis of cyclooxygenase-1 counteracts the suppression of platelet thromboxane biosynthesis by aspirin. Circ Res 2006;98:593–5
   PubMed Web of Science ®Google Scholar
• Berndt MC, Karunakaran D, Gardiner EE, Andrews RK. Programmed autologous cleavage of platelet receptors. J Thromb Haemost 2007;5:212–19
   PubMed Web of Science ®Google Scholar
• Fong KP, Barry C, Tran AN, et al. Deciphering the human platelet sheddome. Blood 2011;117:e15–26
   PubMed Web of Science ®Google Scholar
• Bergmeier W, Rabie T, Strehl A, et al. GPVI down-regulation in murine platelets through metalloproteinase-dependent shedding. Thromb Haemost 2004;91:951–8
   PubMed Web of Science ®Google Scholar
• Bergmeier W, Piffath CL, Cheng G, et al. Tumor necrosis factor-alpha-converting enzyme (ADAM17) mediates GPIbalpha shedding from platelets in vitro and in vivo. Circ Res 2004;95:677–83
   PubMed Web of Science ®Google Scholar
• Facey A, Pinar I, Arthur JF, et al. A-Disintegrin-And-Metalloproteinase (ADAM) 10 activity on resting and activated platelets. Biochemistry 2016;55:1187–94
   PubMed Web of Science ®Google Scholar
• Zonneveld R, Martinelli R, Shapiro NI, et al. Soluble adhesion molecules as markers for sepsis and the potential pathophysiological discrepancy in neonates, children and adults. Crit Care 2014;18:204
   PubMed Web of Science ®Google Scholar
• Dole VS, Bergmeier W, Patten IS, et al. PSGL-1 regulates platelet P-selectin-mediated endothelial activation and shedding of P-selectin from activated platelets. Thromb Haemost 2007;98:806–12
   PubMed Web of Science ®Google Scholar
• Machlus KR, Thon JN, Italiano JE, Jr. Interpreting the developmental dance of the megakaryocyte: a review of the cellular and molecular processes mediating platelet formation. Br J Haematol 2014;165:227–36
   PubMed Web of Science ®Google Scholar
• Junt T, Schulze H, Chen Z, et al. Dynamic visualization of thrombopoiesis within bone marrow. Science 2007;317:1767–70
   PubMed Web of Science ®Google Scholar
• Wang Y, Hayes V, Jarocha D, et al. Comparative analysis of human ex vivo-generated platelets vs megakaryocyte-generated platelets in mice: a cautionary tale. Blood 2015;125:3627–36
   PubMed Web of Science ®Google Scholar
• Fuentes R, Wang Y, Hirsch J, et al. Infusion of mature megakaryocytes into mice yields functional platelets. J Clin Invest 2010;120:3917–22
   PubMed Web of Science ®Google Scholar
• Hou Y, Carrim N, Wang Y, et al. Platelets in hemostasis and thrombosis: novel mechanisms of fibrinogen-independent platelet aggregation and fibronectin-mediated protein wave of hemostasis. J Biomed Res 2015;29:437–44
   Web of Science ®Google Scholar
• Kaushansky K. Thrombopoiesis. Semin Hematol 2015;52:4–11
   PubMed Web of Science ®Google Scholar
• Kuter DJ. Milestones in understanding platelet production: a historical overview. Br J Haematol 2014;165:248–58
   PubMed Web of Science ®Google Scholar
• Kuter DJ. The biology of thrombopoietin and thrombopoietin receptor agonists. Int J Hematol 2013;98:10–23
   PubMed Web of Science ®Google Scholar
• Bussel JB, Kuter DJ, Aledort LM, et al. A randomized trial of avatrombopag, an investigational thrombopoietin-receptor agonist, in persistent and chronic immune thrombocytopenia. Blood 2014;123:3887–94
   PubMed Web of Science ®Google Scholar
• Nishimura S, Nagasaki M, Kunishima S, et al. IL-1alpha induces thrombopoiesis through megakaryocyte rupture in response to acute platelet needs. J Cell Biol 2015;209:453–66
   PubMed Web of Science ®Google Scholar
• Italiano JE, Hartwig JH. Chapter 2: megakaryocyte development and platelet formation. In: Michelson AD, ed. Platelets. 3rd ed. Amsterdam: Academic Press/Elsevier, 2013:27–49
   Google Scholar
• Balduini A, Di Buduo CA, Kaplan DL. Translational approaches to functional platelet production ex vivo. Thromb Haemost 2015;115:250–6
   PubMed Web of Science ®Google Scholar
• Xu M, Ma L, Carrim N, et al. Platelet GPIba is important for thrombopoietin production and thrombopoietin-induced platelet generation. Blood 2015;126:12
   Web of Science ®Google Scholar
• Kile BT. The role of apoptosis in megakaryocytes and platelets. Br J Haematol 2014;165:217–26
   PubMed Web of Science ®Google Scholar
• Leytin V. Apoptosis in the anucleate platelet. Blood Rev 2012;26:51–63
   PubMed Web of Science ®Google Scholar
• Leytin V, Mykhaylov S, Starkey AF, et al. Intravenous immunoglobulin inhibits anti-glycoprotein IIb-induced platelet apoptosis in a murine model of immune thrombocytopenia. Br J Haematol 2006;133:78–82
   PubMed Web of Science ®Google Scholar
• Nieswandt B, Bergmeier W, Rackebrandt K, et al. Identification of critical antigen-specific mechanisms in the development of immune thrombocytopenic purpura in mice. Blood 2000;96:2520–7
   PubMed Web of Science ®Google Scholar
• Li J, van der Wal DE, Zhu L, et al. Fc-independent phagocytosis: implications for IVIG and other therapies in immune-mediated thrombocytopenia. Cardiovasc Hematol Disord Drug Targets 2013;13:50–8
   PubMedGoogle Scholar
• Grozovsky R, Giannini S, Falet H, Hoffmeister KM. Regulating billions of blood platelets: glycans and beyond. Blood 2015;126:1877–84
   PubMed Web of Science ®Google Scholar
• Mason KD, Carpinelli MR, Fletcher JI, et al. Programmed anuclear cell death delimits platelet life span. Cell 2007;128:1173–86
   PubMed Web of Science ®Google Scholar
• Maugeri N, Rovere-Querini P, Evangelista V, et al. Neutrophils phagocytose activated platelets in vivo: a phosphatidylserine, P-selectin, and {beta}2 integrin-dependent cell clearance program. Blood 2009;113:5254–65
   PubMed Web of Science ®Google Scholar
• Miyanishi M, Tada K, Koike M, et al. Identification of Tim4 as a phosphatidylserine receptor. Nature 2007;450:435–9
   PubMed Web of Science ®Google Scholar
• Rand ML, Wang H, Bang KW, et al. Rapid clearance of procoagulant platelet-derived microparticles from the circulation of rabbits. J Thromb Haemost 2006;4:1621–3
   PubMed Web of Science ®Google Scholar
• Li J, van der Wal DE, Zhu G, et al. Desialylation is a mechanism of Fc-independent platelet clearance and a therapeutic target in immune thrombocytopenia. Nat Commun 2015;6:7737
   PubMed Web of Science ®Google Scholar
• Jansen AJ, Peng J, Zhao HG, et al. Sialidase inhibition to increase platelet counts: a new treatment option for thrombocytopenia. Am J Hematol 2015;90:E94–5
   PubMed Web of Science ®Google Scholar
• Grewal PK, Uchiyama S, Ditto D, et al. The Ashwell receptor mitigates the lethal coagulopathy of sepsis. Nat Med 2008;14:648–55
   PubMed Web of Science ®Google Scholar
• Rumjantseva V, Grewal PK, Wandall HH, et al. Dual roles for hepatic lectin receptors in the clearance of chilled platelets. Nat Med 2009;15:1273–80
   PubMed Web of Science ®Google Scholar
• Grozovsky R, Begonja AJ, Liu K, et al. The Ashwell-Morell receptor regulates hepatic thrombopoietin production via JAK2-STAT3 signaling. Nat Med 2015;21:47–54
   PubMed Web of Science ®Google Scholar
• van der Wal D, Zhu G, Li J, et al. Desialylation: a novel platelet clearance mechanism and a potential new therapeutic target in anti-GPIb antibody mediated thrombocytopenia. Blood 2012;120:265
   Google Scholar
• McMillan R. Antiplatelet antibodies in chronic immune thrombocytopenia and their role in platelet destruction and defective platelet production. Hematol Oncol Clin North Am 2009;23:1163–75
   PubMed Web of Science ®Google Scholar
• Cines DB, Cuker A, Semple JW. Pathogenesis of immune thrombocytopenia. Presse Med 2014;43:e49–59
   PubMedGoogle Scholar
• Kaplan C, Ni H, Freedman J. Chapter 46: alloimmune thrombocytopenia. In: Michelson AD, ed. Platelets. 3rd ed. Amsterdam: Academic Press/Elsevier, 2013:953–70
   Google Scholar
• Bussel J. Diagnosis and management of the fetus and neonate with alloimmune thrombocytopenia. J Thromb Haemost 2009;7:253–7
   PubMed Web of Science ®Google Scholar
• Xu XR, Gallant RC, Ni H. Platelets, immune-mediated thrombocytopenias, and fetal hemorrhage. Thromb Res 2016;141:S76–79
   PubMed Web of Science ®Google Scholar
• Harrington WJ, Minnich V, Hollingsworth JW, Moore CV. Demonstration of a thrombocytopenic factor in the blood of patients with thrombocytopenic purpura. J Lab Clin Med 1951;38:1–10
   PubMed Web of Science ®Google Scholar
• Zhou H, Hou Y, Liu X, et al. Low-dose decitabine promotes megakaryocyte maturation and platelet production in healthy controls and immune thrombocytopenia. Thromb Haemost 2015;113:1021–34
   PubMed Web of Science ®Google Scholar
• Webster ML, Sayeh E, Crow M, et al. Relative efficacy of intravenous immunoglobulin G in ameliorating thrombocytopenia induced by antiplatelet GPIIbIIIa versus GPIbalpha antibodies. Blood 2006;108:943–6
   PubMed Web of Science ®Google Scholar
• Webster ML, Zhu G, Li Y, Ni H. Fc-independent phagocytosis: implications for intravenous IgG therapy in immune thrombocytopenia. Cardiovasc Hematol Disord Drug Targets 2008;8:278–82
   PubMedGoogle Scholar
• Zeng Q, Zhu L, Tao L, et al. Relative efficacy of steroid therapy in immune thrombocytopenia mediated by anti-platelet GPIIbIIIa versus GPIbalpha antibodies. Am J Hematol 2012;87:206–8
   PubMed Web of Science ®Google Scholar
• Nishimoto T, Satoh T, Simpson EK, et al. Predominant autoantibody response to GPIb/IX in a regulatory T-cell-deficient mouse model for immune thrombocytopenia. J Thromb Haemost 2013;11:369–72
   PubMed Web of Science ®Google Scholar
• Beardsley DS, Ertem M. Platelet autoantibodies in immune thrombocytopenic purpura. Transfus Sci 1998;19:237–44
   PubMedGoogle Scholar
• McMillan R. Antiplatelet antibodies in chronic adult immune thrombocytopenic purpura: assays and epitopes. J Pediatr Hematol Oncol 2003;25:S57–61
   PubMed Web of Science ®Google Scholar
• Crow AR, Lazarus AH. Role of Fcgamma receptors in the pathogenesis and treatment of idiopathic thrombocytopenic purpura. J Pediatr Hematol Oncol 2003;25:S14–18
   PubMed Web of Science ®Google Scholar
• Siragam V, Crow AR, Brinc D, et al. Intravenous immunoglobulin ameliorates ITP via activating Fc gamma receptors on dendritic cells. Nat Med 2006;12:688–92
   PubMed Web of Science ®Google Scholar
• Peng J, Ma SH, Liu J, et al. Association of autoantibody specificity and response to intravenous immunoglobulin G therapy in immune thrombocytopenia: a multicenter cohort study. J Thromb Haemost 2014;12:497–504
   PubMed Web of Science ®Google Scholar
• Go RS, Johnston KL, Bruden KC. The association between platelet autoantibody specificity and response to intravenous immunoglobulin G in the treatment of patients with immune thrombocytopenia. Haematologica 2007;92:283–4
   PubMed Web of Science ®Google Scholar
• Li C, Piran S, Chen P, et al. The maternal immune response to fetal platelet GPIbα causes frequent miscarriage in mice that can be prevented by intravenous IgG and anti-FcRn therapies. J Clin Invest 2011;121:4537–47
   PubMed Web of Science ®Google Scholar
• Li J, Callum JL, Lin Y, et al. Severe platelet desialylation in a patient with glycoprotein Ib/IX antibody-mediated immune thrombocytopenia and fatal pulmonary hemorrhage. Haematologica 2014;99:e61–3
   PubMed Web of Science ®Google Scholar
• Shao L, Wu Y, Zhou H, et al. Successful treatment with oseltamivir phosphate in a patient with chronic immune thrombocytopenia positive for anti-GPIb/IX autoantibody. Platelets 2015;26:495–7
   PubMed Web of Science ®Google Scholar
• Olsson B, Andersson PO, Jernas M, et al. T-cell-mediated cytotoxicity toward platelets in chronic idiopathic thrombocytopenic purpura. Nat Med 2003;9:1123–4
   PubMed Web of Science ®Google Scholar
• Chow L, Aslam R, Speck ER, et al. A murine model of severe immune thrombocytopenia is induced by antibody- and CD8+ T cell-mediated responses that are differentially sensitive to therapy. Blood 2010;115:1247–53
   PubMed Web of Science ®Google Scholar
• Guo L, Kapur R, Aslam R, et al. CD20+ B-cell depletion therapy suppresses murine CD8+ T-cell-mediated immune thrombocytopenia Blood 2015;127:735–8
   PubMed Web of Science ®Google Scholar
• Yazdanbakhsh K, Zhong H, Bao W. Immune dysregulation in immune thrombocytopenia (ITP). Semin Hematol 2013;50:S63–7
   PubMedGoogle Scholar
• Aslam R, Hu Y, Gebremeskel S, et al. Thymic retention of CD4 + CD25 + FoxP3+ T regulatory cells is associated with their peripheral deficiency and thrombocytopenia in a murine model of immune thrombocytopenia. Blood 2012;120:2127–32
   PubMed Web of Science ®Google Scholar
• Ma L, Simpson E, Li J, et al. CD8+ T cells are predominantly protective and required for effective steroid therapy in murine models of immune thrombocytopenia. Blood 2015;126:247–56
   PubMed Web of Science ®Google Scholar
• Kaplan C. Foetal and neonatal alloimmune thrombocytopaenia. Orphanet J Rare Dis 2006;1:39
   PubMed Web of Science ®Google Scholar
• Zdravic D, Yougbare I, Vadasz B, et al. Fetal and neonatal alloimmune thrombocytopenia. Semin Fetal Neonatal Med 2016;21:19–27
   PubMed Web of Science ®Google Scholar
• Tiller H, Killie MK, Chen P, et al. Toward a prophylaxis against fetal and neonatal alloimmune thrombocytopenia: induction of antibody-mediated immune suppression and prevention of severe clinical complications in a murine model. Transfusion 2012;52:1446–57
   PubMed Web of Science ®Google Scholar
• Serrarens-Janssen VM, Semmekrot BA, Novotny VM, et al. Fetal/neonatal allo-immune thrombocytopenia (FNAIT): past, present, and future. Obstet Gynecol Surv 2008;63:239–52
   PubMed Web of Science ®Google Scholar
• Vadasz B, Chen P, Yougbaré I, et al. Platelets and platelet alloantigens: lessons from human patients and animal models of fetal and neonatal alloimmune thrombocytopenia. Genes Dis 2015;2:173–85
   Google Scholar
• Tiller H, Killie MK, Husebekk A, et al. Platelet antibodies and fetal growth: maternal antibodies against fetal platelet antigen 1a are strongly associated with reduced birthweight in boys. Acta bstetricia Obstet Gynecol Scand 2012;91:79–86
   PubMed Web of Science ®Google Scholar
• Chen P, Li C, Lang S, et al. Animal model of fetal and neonatal immune thrombocytopenia: role of neonatal Fc receptor in the pathogenesis and therapy. Blood 2010;116:3660–8
   PubMed Web of Science ®Google Scholar
• Ni H, Chen P, Spring CM, et al. A novel murine model of fetal and neonatal alloimmune thrombocytopenia: response to intravenous IgG therapy. Blood 2006;107:2976–83
   PubMed Web of Science ®Google Scholar
• Li C, Chen P, Vadasz B, et al. Co-stimulation with LPS or Poly I:C markedly enhances the anti-platelet immune response and severity of fetal and neonatal alloimmune thrombocytopenia. Thromb Haemost 2013;110:1250–8
   PubMed Web of Science ®Google Scholar
• Yougbare I, Zdravic D, Ni H. Angiogenesis and bleeding disorders in FNAIT. Oncotarget 2015;6:15724–5
   PubMed Web of Science ®Google Scholar
• Butros LJ, Bussel JB. Intracranial hemorrhage in immune thrombocytopenic purpura: a retrospective analysis. J Pediatr Hematol Oncol 2003;25:660–4
   PubMed Web of Science ®Google Scholar
• Mackman N. Triggers, targets and treatments for thrombosis. Nature 2008;451:914–18
   PubMed Web of Science ®Google Scholar
• Ni H, Denis CV, Subbarao S, et al. Persistence of platelet thrombus formation in arterioles of mice lacking both von Willebrand factor and fibrinogen. J Clin Invest 2000;106:385–92
   PubMed Web of Science ®Google Scholar
• Kulkarni S, Dopheide SM, Yap CL, et al. A revised model of platelet aggregation. J Clin Invest 2000;105:783–91
   PubMed Web of Science ®Google Scholar
• Falati S, Gross P, Merrill-Skoloff G, et al. Real-time in vivo imaging of platelets, tissue factor and fibrin during arterial thrombus formation in the mouse. Nat Med 2002;8:1175–81
   PubMed Web of Science ®Google Scholar
• Sachs UJ, Nieswandt B. In vivo thrombus formation in murine models. Circ Res 2007;100:979–91
   PubMed Web of Science ®Google Scholar
• Flaumenhaft R. Thrombus formation reimagined. Blood 2014;124:1697–8
   PubMed Web of Science ®Google Scholar
• Clemetson KJ, Clemetson JM. Chapter 9: platelet Receptors. In: Michelson AD, ed. Platelets. 3rd ed. Amsterdam: Academic Press/Elsevier, 2013:169–94
   Google Scholar
• Ni H, Freedman J. Platelets in hemostasis and thrombosis: role of integrins and their ligands. Transfus Apher Sci 2003;28:257–64
   PubMed Web of Science ®Google Scholar
• Bergmeier W, Hynes RO. Extracellular matrix proteins in hemostasis and thrombosis. Cold Spring Harb Perspect Biol 2012;4:a005132
   Web of Science ®Google Scholar
• Patel S, Huang YW, Reheman A, et al. The cell motility modulator Slit2 is a potent inhibitor of platelet function. Circulation 2012;126:1385–95
   PubMed Web of Science ®Google Scholar
• Vendrig AC, Reheman A, Siraj MA, et al. Glucagon-like peptide 1 receptor activation attenuates platelet aggregation and thrombosis. Diabetes 2016; 65:1714–23
   PubMed Web of Science ®Google Scholar
• Crockett J, Newman DK, Newman PJ. PECAM-1 functions as a negative regulator of laminin-induced platelet activation. J Thromb Haemost 2010;8:1584–93
   PubMed Web of Science ®Google Scholar
• Tourdot BE, Brenner MK, Keough KC, et al. Immunoreceptor tyrosine-based inhibitory motif (ITIM)-mediated inhibitory signaling is regulated by sequential phosphorylation mediated by distinct nonreceptor tyrosine kinases: a case study involving PECAM-1. Biochemistry 2013;52:2597–608
   PubMed Web of Science ®Google Scholar
• Wong C, Liu Y, Yip J, et al. CEACAM1 negatively regulates platelet-collagen interactions and thrombus growth in vitro and in vivo. Blood 2009;113:1818–28
   PubMed Web of Science ®Google Scholar
• Lopez JA, Andrews RK, Afshar-Kharghan V, Berndt MC. Bernard-Soulier syndrome. Blood 1998;91:4397–418
   PubMed Web of Science ®Google Scholar
• Nurden AT. Platelet membrane glycoproteins: a historical review. Semin Thromb Hemost 2014;40:577–84
   PubMed Web of Science ®Google Scholar
• Ewenstein BM. Von Willebrand's disease. Annu Rev Med 1997;48:525–42
   PubMed Web of Science ®Google Scholar
• Martinez J. Congenital dysfibrinogenemia. Curr Opin Hematol 1997;4:357–65
   PubMedGoogle Scholar
• Xu X, Wu J, Zhai Z, et al. A novel fibrinogen Bbeta chain frameshift mutation in a patient with severe congenital hypofibrinogenaemia. Thromb Haemost 2006;95:931–5
   PubMed Web of Science ®Google Scholar
• Ruggeri ZM, Jackson SP. Chapter 20: platelet thrombus formation in flowing blood. In: Michelson AD, ed. Platelets. 3rd ed. Amsterdam: Academic Press/Elsevier, 2013;399–424
   Google Scholar
• Jackson SP. The growing complexity of platelet aggregation. Blood 2007;109:5087–95
   PubMed Web of Science ®Google Scholar
• Lopez JA, Dong JF. Structure and function of the glycoprotein Ib-IX-V complex. Curr Opin Hematol 1997;4:323–9
   PubMedGoogle Scholar
• Luo SZ, Mo X, Afshar-Kharghan V, et al. Glycoprotein Ibalpha forms disulfide bonds with 2 glycoprotein Ibbeta subunits in the resting platelet. Blood 2007;109:603–9
   PubMed Web of Science ®Google Scholar
• Zhou L, Yang W, Li R. Analysis of inter-subunit contacts reveals the structural malleability of extracellular domains in platelet glycoprotein Ib-IX complex. J Thromb Haemost 2014;12:82–9
   PubMed Web of Science ®Google Scholar
• Ni H, Ramakrishnan V, Ruggeri ZM, et al. Increased thrombogenesis and embolus formation in mice lacking glycoprotein V. Blood 2001;98:368–73
   PubMed Web of Science ®Google Scholar
• Moog S, Mangin P, Lenain N, et al. Platelet glycoprotein V binds to collagen and participates in platelet adhesion and aggregation. Blood 2001;98:1038–46
   PubMed Web of Science ®Google Scholar
• Ramakrishnan V, DeGuzman F, Bao M, et al. A thrombin receptor function for platelet glycoprotein Ib-IX unmasked by cleavage of glycoprotein V. Proc Natl Acad Sci USA 2001;98:1823–8
   PubMed Web of Science ®Google Scholar
• Nieswandt B, Brakebusch C, Bergmeier W, et al. Glycoprotein VI but not alpha2beta1 integrin is essential for platelet interaction with collagen. EMBO J 2001;20:2120–30
   PubMed Web of Science ®Google Scholar
• Lee RH, Bergmeier W. Platelet immunoreceptor tyrosine-based activation motif (ITAM) and hemITAM signaling and vascular integrity in inflammation and development. J Thromb Haemost 2016;14:645–54
   PubMed Web of Science ®Google Scholar
• Gibbins J, Asselin J, Farndale R, et al. Tyrosine phosphorylation of the Fc receptor gamma-chain in collagen-stimulated platelets. J Biol Chem 1996;271:18095–9
   PubMed Web of Science ®Google Scholar
• Poole A, Gibbins JM, Turner M, et al. The Fc receptor gamma-chain and the tyrosine kinase Syk are essential for activation of mouse platelets by collagen. EMBO J 1997;16:2333–41
   PubMed Web of Science ®Google Scholar
• Yanaga F, Poole A, Asselin J, et al. Syk interacts with tyrosine-phosphorylated proteins in human platelets activated by collagen and cross-linking of the Fc gamma-IIA receptor. Biochem J 1995;311:471–8
   PubMed Web of Science ®Google Scholar
• Nieswandt B, Watson SP. Platelet-collagen interaction: is GPVI the central receptor? Blood 2003;102:449–61
   PubMed Web of Science ®Google Scholar
• Varga-Szabo D, Pleines I, Nieswandt B. Cell adhesion mechanisms in platelets. Arterioscler Thromb Vasc Biol 2008;28:403–12
   PubMed Web of Science ®Google Scholar
• Santoro SA, Zutter MM. The alpha 2 beta 1 integrin: a collagen receptor on platelets and other cells. Thromb Haemost 1995;74:813–21
   PubMed Web of Science ®Google Scholar
• Mazzucato M, Cozzi MR, Battiston M, et al. Distinct spatio-temporal Ca2+ signaling elicited by integrin alpha2beta1 and glycoprotein VI under flow. Blood 2009;114:2793–801
   PubMed Web of Science ®Google Scholar
• Savage B, Almus-Jacobs F, Ruggeri ZM. Specific synergy of multiple substrate-receptor interactions in platelet thrombus formation under flow. Cell 1998;94:657–66
   PubMed Web of Science ®Google Scholar
• Savage B, Saldivar E, Ruggeri ZM. Initiation of platelet adhesion by arrest onto fibrinogen or translocation on von Willebrand factor. Cell 1996;84:289–97
   PubMed Web of Science ®Google Scholar
• Mazzucato M, Pradella P, Cozzi MR, et al. Sequential cytoplasmic calcium signals in a 2-stage platelet activation process induced by the glycoprotein Ibalpha mechanoreceptor. Blood 2002;100:2793–800
   PubMed Web of Science ®Google Scholar
• Bynagari-Settipalli YS, Cornelissen I, Palmer D, et al. Redundancy and interaction of thrombin- and collagen-mediated platelet activation in tail bleeding and carotid thrombosis in mice. Arterioscler Thromb Vasc Biol 2014;34:2563–9
   PubMed Web of Science ®Google Scholar
• Brass LF, Newman DK, Wannemacher KM, Stalker TJ. Chapter 19: signal transduction during platelet plug formation. In: Michelson AD, ed. Platelets. 3rd ed. Amsterdam: Academic Press/Elsevier, 2013:367–98
   Google Scholar
• Clemetson KJ. Snaclecs (snake C-type lectins) that inhibit or activate platelets by binding to receptors. Toxicon 2010;56:1236–46
   PubMed Web of Science ®Google Scholar
• Lei X, Reheman A, Hou Y, et al. Anfibatide, a novel GPIb complex antagonist, inhibits platelet adhesion and thrombus formation in vitro and in vivo in murine models of thrombosis. Thromb Haemost 2014;111:279–89
   PubMed Web of Science ®Google Scholar
• Li B, Dai X, Yang Z, et al. First ex vivo and in vivo assessment of anfibatide, a novel glycoprotein Ib-IV-V complex antagonist, in healthy human volunteers in phase I clinical trial. J Thromb Haemost 2013;11:23
   Web of Science ®Google Scholar
• Hou Y, Li BX, Dai X, et al. The first in vitro and in vivo assessment of anfibatide, a novel glycoprotein ib antagonist, in mice and in a phase i human clinical trial. Blood 2013;122:577
   Google Scholar
• Metharom P, Berndt MC, Baker RI, Andrews RK. Current state and novel approaches of antiplatelet therapy. Arterioscler Thromb Vasc Biol 2015;35:1327–38
   PubMed Web of Science ®Google Scholar
• Xiao T, Takagi J, Coller BS, et al. Structural basis for allostery in integrins and binding to fibrinogen-mimetic therapeutics. Nature 2004;432:59–67
   PubMed Web of Science ®Google Scholar
• Savage B, Cattaneo M, Ruggeri ZM. Mechanisms of platelet aggregation. Curr Opin Hematol 2001;8:270–6
   PubMed Web of Science ®Google Scholar
• Ware J, Russell S, Ruggeri ZM. Generation and rescue of a murine model of platelet dysfunction: the Bernard-Soulier syndrome. Proc Natl Acad Sci USA 2000;97:2803–8
   PubMed Web of Science ®Google Scholar
• Coller BS. Platelet GPIIb/IIIa antagonists: the first anti-integrin receptor therapeutics. J Clin Invest 1997;99:1467–71
   PubMed Web of Science ®Google Scholar
• Scarborough RM, Kleiman NS, Phillips DR. Platelet glycoprotein IIb/IIIa antagonists. What are the relevant issues concerning their pharmacology and clinical use? Circulation 1999;100:437–44
   PubMed Web of Science ®Google Scholar
• Brinkhous KM, Mason RG. Fibrinogen: requirement for platelet aggregation and adhesion. Acta Univ Carol Med Monogr 1972;53:9–16
   PubMedGoogle Scholar
• Yang H, Reheman A, Chen P, et al. Fibrinogen and von Willebrand factor-independent platelet aggregation in vitro and in vivo. J Thromb Haemost 2006;4:2230–7
   PubMed Web of Science ®Google Scholar
• Reheman A, Yang H, Zhu G, et al. Plasma fibronectin depletion enhances platelet aggregation and thrombus formation in mice lacking fibrinogen and von Willebrand factor. Blood 2009;113:1809–17
   PubMed Web of Science ®Google Scholar
• Jirouskova M, Chereshnev I, Vaananen H, et al. Antibody blockade or mutation of the fibrinogen gamma-chain C-terminus is more effective in inhibiting murine arterial thrombus formation than complete absence of fibrinogen. Blood 2004;103:1995–2002
   PubMed Web of Science ®Google Scholar
• Wang Y, Reheman A, Spring CM, et al. Plasma fibronectin supports hemostasis and regulates thrombosis. J Clin Invest 2014;124:4281–93
   PubMed Web of Science ®Google Scholar
• Ni H, Li A, Simonsen N, Wilkins JA. Integrin activation by dithiothreitol or Mn2+ induces a ligand-occupied conformation and exposure of a novel NH2-terminal regulatory site on the beta1 integrin chain. J Biol Chem 1998;273:7981–7
   PubMed Web of Science ®Google Scholar
• Smith JW, Le Calvez H, Parra-Gessert L, et al. Selection and structure of ion-selective ligands for platelet integrin alpha IIb(beta) 3. J Biol Chem 2002;277:10298–305
   PubMed Web of Science ®Google Scholar
• Hynes RO. Integrins: bidirectional, allosteric signaling machines. Cell 2002;110:673–87
   PubMed Web of Science ®Google Scholar
• Luo BH, Carman CV, Springer TA. Structural basis of integrin regulation and signaling. Annu Rev Immunol 2007;25:619–47
   PubMed Web of Science ®Google Scholar
• Ni H, Wilkins JA. Localisation of a novel adhesion blocking epitope on the human beta 1 integrin chain. Cell Adhes Commun 1998;5:257–71
   PubMed Web of Science ®Google Scholar
• Mou Y, Ni H, Wilkins JA. The selective inhibition of beta 1 and beta 7 integrin-mediated lymphocyte adhesion by bacitracin. J Immunol 1998;161:6323–9
   PubMed Web of Science ®Google Scholar
• Tsuji S, Sugimoto M, Miyata S, et al. Real-time analysis of mural thrombus formation in various platelet aggregation disorders: distinct shear-dependent roles of platelet receptors and adhesive proteins under flow. Blood 1999;94:968–75
   PubMed Web of Science ®Google Scholar
• Ni H, Yuen PS, Papalia JM, et al. Plasma fibronectin promotes thrombus growth and stability in injured arterioles. Proc Natl Acad Sci USA 2003;100:2415–19
   PubMed Web of Science ®Google Scholar
• Ni H. Unveiling the new face of fibronectin in thrombosis and hemostasis. J Thromb Haemost 2006;4:940–2
   PubMed Web of Science ®Google Scholar
• Wang Y, Ni H. Fibronectin maintains the balance between hemostasis and thrombosis. Cell Mol Life Sci 2016. [Epub ahead of print]. doi: 10.1007/s00018-016-2225-y
   Google Scholar
• Wang Y, Carrim N, Ni H. Fibronectin orchestrates thrombosis and hemostasis. Oncotarget 2015;6:19350–1
   PubMed Web of Science ®Google Scholar
• Frenette PS, Wagner DD. Adhesion molecules–part II: blood vessels and blood cells. N Engl J Med 1996;335:43–5
   PubMed Web of Science ®Google Scholar
• Wang Y, Ni H. Fibronectin: extra domain brings extra risk? Blood 2015;125:3043–4
   PubMed Web of Science ®Google Scholar
• Eikelboom JW, Quinlan DJ, van Ryn J, Weitz JI. Idarucizumab: the antidote for reversal of dabigatran. Circulation 2015;132:2412–22
   PubMed Web of Science ®Google Scholar
• Eltringham-Smith LJ, Lei X, Reheman A, et al. The fibrinogen but not the Factor VIII content of transfused plasma determines its effectiveness at reducing bleeding in coagulopathic mice. Transfusion 2015;55:1040–50
   PubMed Web of Science ®Google Scholar
• Bonnefoy A, Daenens K, Feys HB, et al. Thrombospondin-1 controls vascular platelet recruitment and thrombus adherence in mice by protecting (sub) endothelial VWF from cleavage by ADAMTS13. Blood 2006;107:955–64
   PubMed Web of Science ®Google Scholar
• Prakash P, Kulkarni PP, Chauhan AK. Thrombospondin 1 requires von Willebrand factor to modulate arterial thrombosis in mice. Blood 2015;125:399–406
   PubMed Web of Science ®Google Scholar
• Dunne E, Spring CM, Reheman A, et al. Cadherin 6 has a functional role in platelet aggregation and thrombus formation. Arterioscler Thromb Vasc Biol 2012;32:1724–31
   PubMed Web of Science ®Google Scholar
• Bouchard BA, Silveira JR, Tracy PB. Chapter 21: interactions between platelets and the coagulation system. In: Michelson AD, ed. Platelets. 3rd ed. Amsterdam: Academic Press/Elsevier, 2013:425–52
   Google Scholar
• Gui T, Reheman A, Funkhouser WK, et al. In vivo response to vascular injury in the absence of factor IX: examination in factor IX knockout mice. Thromb Res 2007;121:225–34
   PubMed Web of Science ®Google Scholar
• Gui T, Reheman A, Ni H, et al. Abnormal hemostasis in a knock-in mouse carrying a variant of factor IX with impaired binding to collagen type IV. J Thromb Haemost 2009;7:1843–51
   PubMed Web of Science ®Google Scholar
• Suzuki J, Umeda M, Sims PJ, Nagata S. Calcium-dependent phospholipid scrambling by TMEM16F. Nature 2010;468:834–8
   PubMed Web of Science ®Google Scholar
• Zwaal RF, Comfurius P, Bevers EM. Scott syndrome, a bleeding disorder caused by defective scrambling of membrane phospholipids. Biochimica Et Biophysica Acta 2004;1636:119–28
   PubMed Web of Science ®Google Scholar
• Coughlin SR. Protease-activated receptors in hemostasis, thrombosis and vascular biology. J Thromb Haemost 2005;3:1800–14
   PubMed Web of Science ®Google Scholar
• Reheman A, Xu X, Reddy EC, Ni H. Targeting activated platelets and fibrinolysis: hitting two birds with one stone. Circ Res 2014;114:1070–3
   PubMed Web of Science ®Google Scholar
• Mozaffarian D, Benjamin EJ, Go AS, et al. Heart disease and stroke statistics-2016 update: a report from the american heart association. Circulation 2016;133:e38–e360
   PubMed Web of Science ®Google Scholar
• Furie B, Furie BC. Mechanisms of thrombus formation. N Engl J Med 2008;359:938–49
   PubMed Web of Science ®Google Scholar
• Palabrica T, Lobb R, Furie BC, et al. Leukocyte accumulation promoting fibrin deposition is mediated in vivo by P-selectin on adherent platelets. Nature 1992;359:848–51
   PubMed Web of Science ®Google Scholar
• Falati S, Liu Q, Gross P, et al. Accumulation of tissue factor into developing thrombi in vivo is dependent upon microparticle P-selectin glycoprotein ligand 1 and platelet P-selectin. J Exp Med 2003;197:1585–98
   PubMed Web of Science ®Google Scholar
• Chou J, Mackman N, Merrill-Skoloff G, et al. Hematopoietic cell-derived microparticle tissue factor contributes to fibrin formation during thrombus propagation. Blood 2004;104:3190–7
   PubMed Web of Science ®Google Scholar
• Polgar J, Matuskova J, Wagner DD. The P-selectin, tissue factor, coagulation triad. J Thromb Haemost 2005;3:1590–6
   PubMed Web of Science ®Google Scholar
• Hrachovinova I, Cambien B, Hafezi-Moghadam A, et al. Interaction of P-selectin and PSGL-1 generates microparticles that correct hemostasis in a mouse model of hemophilia A. Nat Med 2003;9:1020–5
   PubMed Web of Science ®Google Scholar
• Reinhardt C, von Bruhl ML, Manukyan D, et al. Protein disulfide isomerase acts as an injury response signal that enhances fibrin generation via tissue factor activation. J Clin Invest 2008;118:1110–22
   PubMed Web of Science ®Google Scholar
• Carrim N, Zhu G, Reddy EC, et al. Integrin PSI domain has endogenous thiol isomerase function and is a novel target for anti-thrombotic therapy. J Thromb Haemost 2015;13:60
   Web of Science ®Google Scholar
• Andre P, Prasad KS, Denis CV, et al. CD40L stabilizes arterial thrombi by a beta3 integrin-dependent mechanism. Nat Med 2002;8:247–52
   PubMed Web of Science ®Google Scholar
• Jilma-Stohlawetz P, Gorczyca ME, Jilma B, et al. Inhibition of von Willebrand factor by ARC1779 in patients with acute thrombotic thrombocytopenic purpura. Thromb Haemost 2011;105:545–52
   PubMed Web of Science ®Google Scholar
• Ungerer M, Rosport K, Bultmann A, et al. Novel antiplatelet drug revacept (Dimeric Glycoprotein VI-Fc) specifically and efficiently inhibited collagen-induced platelet aggregation without affecting general hemostasis in humans. Circulation 2011;123:1891–9
   PubMed Web of Science ®Google Scholar
• GmbH A. Revacept in symptomatic carotid stenosis (Revacept/CS/02). [Online]. Available from: http://clinicaltrials.gov/ct2/show/NCT01645306 [last accessed 9 Jun, 2016]
   Google Scholar
• Becker RC, Moliterno DJ, Jennings LK, et al. Safety and tolerability of SCH 530348 in patients undergoing non-urgent percutaneous coronary intervention: a randomised, double-blind, placebo-controlled phase II study. Lancet 2009;373:919–28
   PubMed Web of Science ®Google Scholar
• Serebruany VL, Fortmann SD. The FDA report on vorapaxar in the elderly: a convoluted dilemma. Int J Cardiol 2015;201:601–3
   PubMed Web of Science ®Google Scholar
• Fanola CL. Current and emerging strategies in the management of venous thromboembolism: benefit-risk assessment of dabigatran. Vasc Health Risk Manag 2015;11:271–82
   PubMedGoogle Scholar
• Aleman MM, Walton BL, Byrnes JR, Wolberg AS. Fibrinogen and red blood cells in venous thrombosis. Thromb Res 2014;133:S38–40
   PubMed Web of Science ®Google Scholar
• Sevitt S. The structure and growth of valve-pocket thrombi in femoral veins. J Clin Pathol 1974;27:517–28
   PubMed Web of Science ®Google Scholar
• Engelmann B, Massberg S. Thrombosis as an intravascular effector of innate immunity. Nat Rev Immunol 2013;13:34–45
   PubMed Web of Science ®Google Scholar
• Brill A, Fuchs TA, Chauhan AK, et al. von Willebrand factor-mediated platelet adhesion is critical for deep vein thrombosis in mouse models. Blood 2011;117:1400–7
   PubMed Web of Science ®Google Scholar
• Von Bruhl ML, Stark K, Steinhart A, et al. Monocytes, neutrophils, and platelets cooperate to initiate and propagate venous thrombosis in mice in vivo. J Exp Med 2012;209:819–35
   PubMed Web of Science ®Google Scholar
• Maugeri N, Brambilla M, Camera M, et al. Human polymorphonuclear leukocytes produce and express functional tissue factor upon stimulation. J Thromb Haemost 2006;4:1323–30
   PubMed Web of Science ®Google Scholar
• Wolberg AS, Monroe DM, Roberts HR, Hoffman MR. Tissue factor de-encryption: ionophore treatment induces changes in tissue factor activity by phosphatidylserine-dependent and -independent mechanisms. Blood Coagul Fibrinolysis 1999;10:201–10
   PubMed Web of Science ®Google Scholar
• Brill A, Fuchs TA, Savchenko AS, et al. Neutrophil extracellular traps promote deep vein thrombosis in mice. J Thromb Haemost 2012;10:136–44
   PubMed Web of Science ®Google Scholar
• Fuchs TA, Brill A, Duerschmied D, et al. Extracellular DNA traps promote thrombosis. Proc Natl Acad Sci USA 2010;107:15880–5
   PubMed Web of Science ®Google Scholar
• Fuchs TA, Bhandari AA, Wagner DD. Histones induce rapid and profound thrombocytopenia in mice. Blood 2011;118:3708–14
   PubMed Web of Science ®Google Scholar
• Semeraro F, Ammollo CT, Morrissey JH, et al. Extracellular histones promote thrombin generation through platelet-dependent mechanisms: involvement of platelet TLR2 and TLR4. Blood 2011;118:1952–61
   PubMed Web of Science ®Google Scholar
• Fuchs TA, Brill A, Wagner DD. Neutrophil extracellular trap (NET) impact on deep vein thrombosis. Arterioscler Thromb Vasc Biol 2012;32:1777–83
   PubMed Web of Science ®Google Scholar
• Rautou PE, Mackman N. Microvesicles as risk markers for venous thrombosis. Expert Rev Hematol 2013;6:91–101
   PubMed Web of Science ®Google Scholar
• Mackman N. Role of tissue factor in hemostasis and thrombosis. Blood Cells Mol Dis 2006;36:104–7
   PubMed Web of Science ®Google Scholar
• Castellucci LA, Cameron C, Le Gal G, et al. Clinical and safety outcomes associated with treatment of acute venous thromboembolism: a systematic review and meta-analysis. JAMA 2014;312:1122–35
   PubMed Web of Science ®Google Scholar
• Sharma M, Cornelius VR, Patel JP, et al. Efficacy and harms of direct oral anticoagulants in the elderly for stroke prevention in atrial fibrillation and secondary prevention of venous thromboembolism: systematic review and meta-analysis. Circulation 2015;132:194–204
   PubMed Web of Science ®Google Scholar
• Mekaj YH, Daci FT, Mekaj AY. New insights into the mechanisms of action of aspirin and its use in the prevention and treatment of arterial and venous thromboembolism. Ther Clin Risk Manag 2015;11:1449–56
   PubMed Web of Science ®Google Scholar
• Becattini C, Agnelli G. Aspirin for prevention and treatment of venous thromboembolism. Blood Rev 2014;28:103–8
   PubMed Web of Science ®Google Scholar
• Brinkmann V, Reichard U, Goosmann C, et al. Neutrophil extracellular traps kill bacteria. Science 2004;303:1532–5
   PubMed Web of Science ®Google Scholar
• Savchenko AS, Borissoff JI, Martinod K, et al. VWF-mediated leukocyte recruitment with chromatin decondensation by PAD4 increases myocardial ischemia/reperfusion injury in mice. Blood 2014;123:141–8
   PubMed Web of Science ®Google Scholar
• McMorran BJ, Marshall VM, de Graaf C, et al. Platelets kill intraerythrocytic malarial parasites and mediate survival to infection. Science 2009;323:797–800
   PubMed Web of Science ®Google Scholar
• McMorran BJ, Wieczorski L, Drysdale KE, et al. Platelet factor 4 and Duffy antigen required for platelet killing of Plasmodium falciparum. Science 2012;338:1348–51
   PubMed Web of Science ®Google Scholar
• Aslam R, Speck ER, Kim M, et al. Platelet Toll-like receptor expression modulates lipopolysaccharide-induced thrombocytopenia and tumor necrosis factor-alpha production in vivo. Blood 2006;107:637–41
   PubMed Web of Science ®Google Scholar
• Zhang G, Han J, Welch EJ, et al. Lipopolysaccharide stimulates platelet secretion and potentiates platelet aggregation via TLR4/MyD88 and the cGMP-dependent protein kinase pathway. J Immunol 2009;182:7997–8004
   PubMed Web of Science ®Google Scholar
• Clark SR, Ma AC, Tavener SA, et al. Platelet TLR4 activates neutrophil extracellular traps to ensnare bacteria in septic blood. Nat Med 2007;13:463–9
   PubMed Web of Science ®Google Scholar
• Alexander WS, Roberts AW, Nicola NA, et al. Deficiencies in progenitor cells of multiple hematopoietic lineages and defective megakaryocytopoiesis in mice lacking the thrombopoietic receptor c-Mpl. Blood 1996;87:2162–70
   PubMed Web of Science ®Google Scholar
• Norgaard M, Jensen AO, Engebjerg MC, et al. Long-term clinical outcomes of patients with primary chronic immune thrombocytopenia: a Danish population-based cohort study. Blood 2011;117:3514–20
   PubMed Web of Science ®Google Scholar
• Kerrigan SW, Douglas I, Wray A, et al. A role for glycoprotein Ib in Streptococcus sanguis-induced platelet aggregation. Blood 2002;100:509–16
   PubMed Web of Science ®Google Scholar
• Tilley DO, Arman M, Smolenski A, et al. Glycoprotein Ibalpha and FcgammaRIIa play key roles in platelet activation by the colonizing bacterium, Streptococcus oralis. J Thromb Haemost 2013;11:941–50
   PubMed Web of Science ®Google Scholar
• Chaipan C, Soilleux EJ, Simpson P, et al. DC-SIGN and CLEC-2 mediate human immunodeficiency virus type 1 capture by platelets. J Virol 2006;80:8951–60
   PubMed Web of Science ®Google Scholar
• Simon AY, Sutherland MR, Pryzdial EL. Dengue virus binding and replication by platelets. Blood 2015;126:378–85
   PubMed Web of Science ®Google Scholar
• Stenberg PE, McEver RP, Shuman MA, et al. A platelet alpha-granule membrane protein (GMP-140) is expressed on the plasma membrane after activation. J Cell Biol 1985;101:880–6
   PubMed Web of Science ®Google Scholar
• Bonfanti R, Furie BC, Furie B, Wagner DD. PADGEM (GMP140) is a component of Weibel-Palade bodies of human endothelial cells. Blood 1989;73:1109–12
   PubMed Web of Science ®Google Scholar
• Yang J, Furie BC, Furie B. The biology of P-selectin glycoprotein ligand-1: its role as a selectin counterreceptor in leukocyte-endothelial and leukocyte-platelet interaction. Thromb Haemost 1999;81:1–7
   PubMed Web of Science ®Google Scholar
• Simon DI, Chen Z, Xu H, et al. Platelet glycoprotein ibalpha is a counterreceptor for the leukocyte integrin Mac-1 (CD11b/CD18). J Exp Med 2000;192:193–204
   PubMed Web of Science ®Google Scholar
• Mayadas TN, Johnson RC, Rayburn H, et al. Leukocyte rolling and extravasation are severely compromised in P selectin-deficient mice. Cell 1993;74:541–54
   PubMed Web of Science ®Google Scholar
• Chen M, Geng JG. P-selectin mediates adhesion of leukocytes, platelets, and cancer cells in inflammation, thrombosis, and cancer growth and metastasis. Arch Immunol Ther Exp (Warsz) 2006;54:75–84
   PubMed Web of Science ®Google Scholar
• Cerletti C, Tamburrelli C, Izzi B, et al. Platelet-leukocyte interactions in thrombosis. Thromb Res 2012;129:263–6
   PubMed Web of Science ®Google Scholar
• Ghasemzadeh M, Hosseini E. Platelet-leukocyte crosstalk: linking proinflammatory responses to procoagulant state. Thromb Res 2013;131:191–7
   PubMed Web of Science ®Google Scholar
• Felding-Habermann B, O'Toole TE, Smith JW, et al. Integrin activation controls metastasis in human breast cancer. Proc Natl Acad Sci USA 2001;98:1853–8
   PubMed Web of Science ®Google Scholar
• Gould TJ, Lysov Z, Liaw PC. Extracellular DNA and histones: double-edged swords in immunothrombosis. J Thromb Haemost 2015;13:S82–91
   PubMed Web of Science ®Google Scholar
• Martinod K, Wagner DD. Thrombosis: tangled up in NETs. Blood 2014;123:2768–76
   PubMed Web of Science ®Google Scholar
• Massberg S, Grahl L, von Bruehl ML, et al. Reciprocal coupling of coagulation and innate immunity via neutrophil serine proteases. Nat Med 2010;16:887–96
   PubMed Web of Science ®Google Scholar
• Diacovo TG, Puri KD, Warnock RA, et al. Platelet-mediated lymphocyte delivery to high endothelial venules. Science 1996;273:252–5
   PubMed Web of Science ®Google Scholar
• Vestweber D, Wild MK. A new player in lymphocyte homing. Nat Immunol 2008;9:347–8
   PubMed Web of Science ®Google Scholar
• Scheiermann C, Frenette PS, Hidalgo A. Regulation of leucocyte homeostasis in the circulation. Cardiovasc Res 2015;107:340–51
   PubMed Web of Science ®Google Scholar
• Elzey BD, Tian J, Jensen RJ, et al. Platelet-mediated modulation of adaptive immunity. A communication link between innate and adaptive immune compartments. Immunity 2003;19:9–19
   PubMed Web of Science ®Google Scholar
• Elzey BD, Grant JF, Sinn HW, et al. Cooperation between platelet-derived CD154 and CD4+ T cells for enhanced germinal center formation. J Leukoc Biol 2005;78:80–4
   PubMed Web of Science ®Google Scholar
• Shi G, Field DJ, Ko KA, et al. Platelet factor 4 limits Th17 differentiation and cardiac allograft rejection. J Clin Invest 2014;124:543–52
   PubMed Web of Science ®Google Scholar
• Ahamed J, Burg N, Yoshinaga K, et al. In vitro and in vivo evidence for shear-induced activation of latent transforming growth factor-beta1. Blood 2008;112:3650–60
   PubMed Web of Science ®Google Scholar
• McManus DD, Freedman JE. MicroRNAs in platelet function and cardiovascular disease. Nat Rev Cardiol 2015;12:711–17
   PubMed Web of Science ®Google Scholar
• Henn V, Slupsky JR, Grafe M, et al. CD40 ligand on activated platelets triggers an inflammatory reaction of endothelial cells. Nature 1998;391:591–4
   PubMed Web of Science ®Google Scholar
• Sadowski M, Zabczyk M, Undas A. Coronary thrombus composition: links with inflammation, platelet and endothelial markers. Atherosclerosis 2014;237:555–61
   PubMed Web of Science ®Google Scholar
• Langer F, Ingersoll SB, Amirkhosravi A, et al. The role of CD40 in CD40L- and antibody-mediated platelet activation. Thromb Haemost 2005;93:1137–46
   PubMed Web of Science ®Google Scholar
• Badrnya S, Schrottmaier WC, Kral JB, et al. Platelets mediate oxidized low-density lipoprotein-induced monocyte extravasation and foam cell formation. Arterioscler Thromb Vasc Biol 2014;34:571–80
   PubMed Web of Science ®Google Scholar
• Gleissner CA. Platelet-derived chemokines in atherogenesis: what's new? Curr Vasc Pharmacol 2012;10:563–9
   PubMed Web of Science ®Google Scholar
• Glass CK, Witztum JL. Atherosclerosis. the road ahead. Cell 2001;104:503–16
   PubMed Web of Science ®Google Scholar
• Zhou X, Paulsson G, Stemme S, Hansson GK. Hypercholesterolemia is associated with a T helper (Th) 1/Th2 switch of the autoimmune response in atherosclerotic apo E-knockout mice. J Clin Invest 1998;101:1717–25
   PubMed Web of Science ®Google Scholar
• Austrup F, Vestweber D, Borges E, et al. P- and E-selectin mediate recruitment of T-helper-1 but not T-helper-2 cells into inflammed tissues. Nature 1997;385:81–3
   PubMed Web of Science ®Google Scholar
• Dong ZM, Chapman SM, Brown AA, et al. The combined role of P- and E-selectins in atherosclerosis. J Clin Invest 1998;102:145–52
   PubMed Web of Science ®Google Scholar
• Dong ZM, Brown AA, Wagner DD. Prominent role of P-selectin in the development of advanced atherosclerosis in ApoE-deficient mice. Circulation 2000;101:2290–5
   PubMed Web of Science ®Google Scholar
• Burger PC, Wagner DD. Platelet P-selectin facilitates atherosclerotic lesion development. Blood 2003;101:2661–6
   PubMed Web of Science ®Google Scholar
• Podrez EA, Byzova TV, Febbraio M, et al. Platelet CD36 links hyperlipidemia, oxidant stress and a prothrombotic phenotype. Nat Med 2007;13:1086–95
   PubMed Web of Science ®Google Scholar
• Ni H. The platelet in diabetes. Blood 2012;119:5949–51
   PubMed Web of Science ®Google Scholar
• Valiyaveettil M, Kar N, Ashraf MZ, et al. Oxidized high-density lipoprotein inhibits platelet activation and aggregation via scavenger receptor BI. Blood 2008;111:1962–71
   PubMed Web of Science ®Google Scholar
• Yang Y, Andrews MC, Hu Y, et al. Anthocyanin extract from black rice significantly ameliorates platelet hyperactivity and hypertriglyceridemia in dyslipidemic rats induced by high fat diets. J Agric Food Chem 2011;59:6759–64
   PubMed Web of Science ®Google Scholar
• Yang Y, Shi Z, Reheman A, et al. Plant food delphinidin-3-glucoside significantly inhibits platelet activation and thrombosis: novel protective roles against cardiovascular diseases. PloS One 2012;7:e37323
   PubMed Web of Science ®Google Scholar
• Song F, Zhu Y, Shi Z, et al. Plant food anthocyanins inhibit platelet granule secretion in hypercholesterolaemia: involving the signalling pathway of PI3K-Akt. Thromb Haemost 2014;112:981–91
   PubMed Web of Science ®Google Scholar
• Ciatto S, Ambrogetti D, Bonardi R, et al. Prognostic impact of early detection of contralateral primary breast cancer. Tumori 1990;76:370–3
   PubMed Web of Science ®Google Scholar
• Uhrin P, Zaujec J, Breuss JM, et al. Novel function for blood platelets and podoplanin in developmental separation of blood and lymphatic circulation. Blood 2010;115:3997–4005
   PubMed Web of Science ®Google Scholar
• Carramolino L, Fuentes J, Garcia-Andres C, et al. Platelets play an essential role in separating the blood and lymphatic vasculatures during embryonic angiogenesis. Circ Res 2010;106:1197–201
   PubMed Web of Science ®Google Scholar
• Bertozzi CC, Schmaier AA, Mericko P, et al. Platelets regulate lymphatic vascular development through CLEC-2-SLP-76 signaling. Blood 2010;116:661–70
   PubMed Web of Science ®Google Scholar
• Finney BA, Schweighoffer E, Navarro-Nunez L, et al. CLEC-2 and Syk in the megakaryocytic/platelet lineage are essential for development. Blood 2012;119:1747–56
   PubMed Web of Science ®Google Scholar
• Carmeliet P, Jain RK. Angiogenesis in cancer and other diseases. Nature 2000;407:249–57
   PubMed Web of Science ®Google Scholar
• Carmeliet P. Angiogenesis in health and disease. Nat Med 2003;9:653–60
   PubMed Web of Science ®Google Scholar
• Walsh TG, Metharom P, Berndt MC. The functional role of platelets in the regulation of angiogenesis. Platelets 2015;26:199–211
   PubMed Web of Science ®Google Scholar
• Hallberg H, Mattsson B. Premature deaths among men in a Swedish municipality-social characteristics prior to death. Scand J Soc Med 1991;19:181–6
   PubMedGoogle Scholar
• Battinelli EM, Markens BA, Italiano JE, Jr. Release of angiogenesis regulatory proteins from platelet alpha granules: modulation of physiologic and pathologic angiogenesis. Blood 2011;118:1359–69
   PubMed Web of Science ®Google Scholar
• van Nispen tot Pannerden H, de Haas F, Geerts W, et al. The platelet interior revisited: electron tomography reveals tubular alpha-granule subtypes. Blood 2010;116:1147–56
   PubMed Web of Science ®Google Scholar
• Brooks PC, Montgomery AM, Rosenfeld M, et al. Integrin alpha v beta 3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels. Cell 1994;79:1157–64
   PubMed Web of Science ®Google Scholar
• Reynolds LE, Wyder L, Lively JC, et al. Enhanced pathological angiogenesis in mice lacking beta3 integrin or beta3 and beta5 integrins. Nat Med 2002;8:27–34
   PubMed Web of Science ®Google Scholar
• Bridges EM, Harris AL. The angiogenic process as a therapeutic target in cancer. Biochem Pharmacol 2011;81:1183–91
   PubMed Web of Science ®Google Scholar
• Kerbel R, Folkman J. Clinical translation of angiogenesis inhibitors. Nat Rev Cancer 2002;2:727–39
   PubMed Web of Science ®Google Scholar
• Werner S, Grose R. Regulation of wound healing by growth factors and cytokines. Physiol Rev 2003;83:835–70
   PubMed Web of Science ®Google Scholar
• Singer AJ, Clark RA. Cutaneous wound healing. N Engl J Med 1999;341:738–46
   PubMed Web of Science ®Google Scholar
• Verheul HM, Hoekman K, Luykx-de Bakker S, et al. Platelet: transporter of vascular endothelial growth factor. Clin Cancer Res 1997;3:2187–90
   PubMed Web of Science ®Google Scholar
• Pandya NM, Dhalla NS, Santani DD. Angiogenesis: a new target for future therapy. Vascul Pharmacol 2006;44:265–74
   PubMed Web of Science ®Google Scholar
• Guo S, Dipietro LA. Factors affecting wound healing. J Dent Res 2010;89:219–29
   PubMed Web of Science ®Google Scholar
• Lieberman JR, Daluiski A, Einhorn TA. The role of growth factors in the repair of bone. Biology and clinical applications. J Bone Joint Surg Am 2002;84-A:1032–44
   PubMed Web of Science ®Google Scholar
• Walsh TG, Metharom P, Berndt MC. The functional role of platelets in the regulation of angiogenesis. Platelets 2014;7104:1–13
   Google Scholar
• Tranum BL, Haut A. Thrombocytosis: platelet kinetics in neoplasia. J Lab Clin Med 1974;84:615–19
   PubMed Web of Science ®Google Scholar
• Gasic GJ, Gasic TB, Stewart CC. Antimetastatic effects associated with platelet reduction. Proc Natl Acad Sci U S A 1968;61:46–52
   PubMed Web of Science ®Google Scholar
• Erdemir F, Kilciler M, Bedir S, et al. Clinical significance of platelet count in patients with renal cell carcinoma. Urol Int 2007;79:111–16
   PubMed Web of Science ®Google Scholar
• Taucher S, Salat A, Gnant M, et al. Impact of pretreatment thrombocytosis on survival in primary breast cancer. Thromb Haemost 2003;89:1098–106
   PubMed Web of Science ®Google Scholar
• Gay LJ, Felding-Habermann B. Contribution of platelets to tumour metastasis. Nat Rev Cancer 2011;11:123–34
   PubMed Web of Science ®Google Scholar
• Zaslavsky A, Baek KH, Lynch RC, et al. Platelet-derived thrombospondin-1 is a critical negative regulator and potential biomarker of angiogenesis. Blood 2010;115:4605–13
   PubMed Web of Science ®Google Scholar
• Egan K, Cooke N, Kenny D. Living in shear: platelets protect cancer cells from shear induced damage. Clin Exp Metastasis 2014;31:697–704
   PubMed Web of Science ®Google Scholar
• Mitrugno A, Tormoen GW, Kuhn P, McCarty OJ. The prothrombotic activity of cancer cells in the circulation. Blood Rev 2015;30:11–19
   PubMed Web of Science ®Google Scholar
• Coupland LA, Parish CR. Platelets, selectins, and the control of tumor metastasis. Semin Oncol 2014;41:422–34
   PubMed Web of Science ®Google Scholar
• Kopp HG, Placke T, Salih HR. Platelet-derived transforming growth factor-beta down-regulates NKG2D thereby inhibiting natural killer cell antitumor reactivity. Cancer Res 2009;69:7775–83
   PubMed Web of Science ®Google Scholar
• Placke T, Orgel M, Schaller M, et al. Platelet-derived MHC class I confers a pseudonormal phenotype to cancer cells that subverts the antitumor reactivity of natural killer immune cells. Cancer Res 2012;72:440–8
   PubMed Web of Science ®Google Scholar
• Placke T, Kopp HG, Salih HR. The wolf in sheep's clothing: platelet-derived impairs cancer cell recognition by NK cells. Oncoimmunology 2012;1:557–9
   PubMed Web of Science ®Google Scholar
• Goubran HA, Stakiw J, Radosevic M, Burnouf T. Platelet-cancer interactions. Semin Thromb Hemost 2014;40:296–305
   PubMed Web of Science ®Google Scholar
• Amirkhosravi A, Mousa SA, Amaya M, et al. Inhibition of tumor cell-induced platelet aggregation and lung metastasis by the oral GpIIb/IIIa antagonist XV454. Thromb Haemost 2003;90:549–54
   PubMed Web of Science ®Google Scholar
• Desgrosellier JS, Cheresh DA. Integrins in cancer: biological implications and therapeutic opportunities. Nat Rev Cancer 2010;10:9–22
   PubMed Web of Science ®Google Scholar
• Kim YJ, Borsig L, Han HL, et al. Distinct selectin ligands on colon carcinoma mucins can mediate pathological interactions among platelets, leukocytes, and endothelium. Am J Pathol 1999;155:461–72
   PubMed Web of Science ®Google Scholar
• Lebeau B, Chastang C, Brechot JM, et al. Subcutaneous heparin treatment increases survival in small cell lung cancer. “Petites Cellules” Group. Cancer 1994;74:38–45
   PubMed Web of Science ®Google Scholar
• Klerk CP, Smorenburg SM, Otten HM, et al. The effect of low molecular weight heparin on survival in patients with advanced malignancy. J Clin Oncol 2005;23:2130–5
   PubMed Web of Science ®Google Scholar
• Borsig L, Wong R, Feramisco J, et al. Heparin and cancer revisited: mechanistic connections involving platelets, P-selectin, carcinoma mucins, and tumor metastasis. Proc Natl Acad Sci USA 2001;98:3352–7
   PubMed Web of Science ®Google Scholar
• Laubli H, Spanaus KS, Borsig L. Selectin-mediated activation of endothelial cells induces expression of CCL5 and promotes metastasis through recruitment of monocytes. Blood 2009;114:4583–91
   PubMed Web of Science ®Google Scholar
• Qian BZ, Li J, Zhang H, et al. CCL2 recruits inflammatory monocytes to facilitate breast-tumour metastasis. Nature 2011;475:222–5
   PubMed Web of Science ®Google Scholar
• Labelle M, Begum S, Hynes RO. Direct signaling between platelets and cancer cells induces an epithelial-mesenchymal-like transition and promotes metastasis. Cancer Cell 2011;20:576–90
   PubMed Web of Science ®Google Scholar
• Israels SJ. Chapter 25: platelet function in the newborn. In: Michelson AD, ed. Platelets. 3rd ed. Amsterdam: Academic Press/Elsevier, 2013:503–16
   Google Scholar
• Liu ZJ, Hoffmeister KM, Hu Z, et al. Expansion of the neonatal platelet mass is achieved via an extension of platelet lifespan. Blood 2014;123:3381–9
   PubMed Web of Science ®Google Scholar
• Dayal S, Wilson KM, Motto DG, et al. Hydrogen peroxide promotes aging-related platelet hyperactivation and thrombosis. Circulation 2013;127:1308–16
   PubMed Web of Science ®Google Scholar
• Lesurtel M, Graf R, Aleil B, et al. Platelet-derived serotonin mediates liver regeneration. Science 2006;312:104–7
   PubMed Web of Science ®Google Scholar
• Matsuo R, Nakano Y, Ohkohchi N. Platelet administration via the portal vein promotes liver regeneration in rats after 70% hepatectomy. Ann Surg 2011;253:759–63
   PubMed Web of Science ®Google Scholar